comparemela.com

Latest Breaking News On - Summit therapeutics first quarter - Page 1 : comparemela.com

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript

Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06.

Canada
Japan
China
United-states
Texas
Chinese
America
American
Bob-duggan
Allen-yang
Brad-canino
Bradley-canino

Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call. [Operator Instructions].

Hong-kong
China
Australia
Japan
Canada
United-states
Chinese
Michelle-xia
Robert-duggan
Mahkam-zanganeh
Bob-duggan
Dave-gancarz

vimarsana © 2020. All Rights Reserved.